Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 60.81 -1.30%   SPY: 129.74 -0.86%
Quote Spy APPY NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


AspenBio Pharma (APPY)

@ May-18
Click the portfolio to add APPY:
Close [X]
+ Add APPY to Portfolio
  
  Last Trade: $0.56 -0.08 (-12.50%)
  Volume: 8,065 37% of avg daily volume
       
  Avg Volume: 21,941
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.55 - 0.64
  Open: 0.60
  Previous Close: 0.64
  52-wk Range: 0.52 - 3.90
  Market Cap: 5.3M
  P/E: -0.6
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy APPY

? Pro holders
? Member holders
? Items submitted
Additional APPY resources



Customize Links
To see which Pros and tickerspy members own APPY Sign up now
Latest APPY Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
APPY  
Linked by marketwire - November 28, 04:15PM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging in vitro diagnostic company, reported on its recently completed pilot study,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Pharma to Report Results From Recently Completed AppyScore(TM) Pilot Study, Product Profile and Upcoming Milestones
APPY  
Linked by marketwire - November 21, 09:00AM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging in vitro diagnostic company, recently completed its 2011 pilot study of  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Reports Interim Data From AppyScore Pilot Study and Outlook for Regulatory Pathway
APPY  
Linked by marketwire - October 19, 04:05PM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging invitro diagnostic company, reported on its progress with AppyScore(TM),  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Pharma to Hold Investor Update Call on Wednesday, October 19, 2011 at 4:30 p.m. ET
APPY  
Linked by marketwire - October 17, 06:25PM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging in vitro diagnostic company, will host a conference call to report on its  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Adds Erik Miller as Vice President, Marketing and Business Development
APPY  
Linked by marketwire - January 18, 04:30PM from (www2.marketwire.com)
On January 17, 2011, AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging company dedicated to the development of novel human  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Important November 30, 2010 Class Action Deadline Approaching for AspenBio Pharma Shareholders, Says the Rosen Law Firm -- APPY
APPY  
Linked by GlobeNewswire - November 25, 02:22PM from (www.globenewswire.com)
NEW YORK, Nov. 25, 2010 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds investors of the important November 30, 2010 lead  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Rosen Law Firm Reminds Present and Former Investors of AspenBio Pharma of Important November 30, 2010 Lead Plaintiff Deadline -- APPY
APPY  
Linked by GlobeNewswire - October 29, 06:00PM from (www.globenewswire.com)
NEW YORK, Oct. 29, 2010 (GLOBE NEWSWIRE) -- The Rosen Law Firm today reminds investors of the important November 30, 2010  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Streamlines Its Governance Structure
APPY  
Linked by marketwire - October 12, 04:35PM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY), today reported that the Company's Board of Directors has restructured AspenBio Pharma's  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Rosen Law Firm Files Securities Fraud Class Action Against AspenBio Pharma, Inc. -- APPY
APPY  
Linked by GlobeNewswire - October 01, 11:59PM from (www.globenewswire.com)
NEW YORK, Oct. 1, 2010 (GLOBE NEWSWIRE) -- The Rosen Law Firm today announced that it has filed a class action lawsuit on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test
APPY  
Linked by marketwire - July 19, 04:33PM from (www2.marketwire.com)
AspenBio Pharma, Inc. (NASDAQ: APPY) reported results today from the Company's recently completed AppyScore™ ELISA-based  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource